Kaveh, S. (2018) “Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer”, International Pharmacy Acta, 1(1), pp. 19–20. doi: 10.22037/ipa.v1i1.20015.